The global oncology drugs market will witness a robust CAGR of 11.53%, valued at $177.54 billion in 2021, expected to appre... Read More
The global immune oncology assays market will witness a robust CAGR of 11.87%, valued at $3.84 billion in 2021, expected to appreciate an... Read More
The global neuromodulation devices market will witness a robust CAGR of 10.28%, valued at $6.09 billio... Read More
The global patient engagement solutions market will witness a robust CAGR of 20.93%, valued at $13.42 b... Read More
The global ophthalmic devices market will witness a robust CAGR of 4.7%, valued at $54.96 billion in 2021, and expected to appreciate and reach $83.09 bill... Read More
The global cardiac arrhythmia monitoring devices market will witness a robust CAGR of 4.41%, valued at ... Read More
The global cancer monoclonal antibodies market will witness a robust CAGR of 8.54%, valued at $51.88 billion in 2021, exp... Read More
The global recombinant DNA technology market will witness a robust CAGR of 7.7%, valued at $707.20 billion in 2021, expect... Read More
The global immunoassay market will witness a robust CAGR of 7.3%, valued at $24.30 billion in 2021, expected to appreci... Read More
The global sports medicine market will witness a robust CAGR of 6.2%, valued at $6.90 billion in 2021, expected to ap... Read More